Utredning av risiko ved utfasing av rammeavtaler med kommersielle leverandører av institusjonsplasser i barnevernet i Oslo

Report number: OE-rapport 2021-09
Title: Utredning av risiko ved utfasing av rammeavtaler med kommersielle leverandører av institusjonsplasser i barnevernet i Oslo
Client: Barne- og familieetaten i Oslo kommune
Published: February 21
Link: PDF

See all publications

Newest articles

Court of Appeals: Excluding commercial providers from public procurement of nursing homes was unlawful

In a case between Oslo municipality and two commercial providers of nursing homes (Norlandia and Stendi), Borgarting Court of Appeals has decided that Oslo municipality’s exclusion of commercial providers from a public procurement of nursing home services was unlawful.

Study reveals potential for improving adherence to lipid lowering treatment

Our recently published study on adherence to lipid-lowering drugs was featured in a newspaper article in Dagens Medisin. Our study tracks all patients in Norway who initiated treatment with proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9 mAbs) from 2015 to 2023.

Alternative clinical endpoints: The path to better treatment?

On November 27, Oslo Economics and Bristol Myers Squibb are hosting a breakfast meeting on the healthcare system’s structure and its ability to prioritize in today’s rapidly evolving technological landscape.
Join us to hear presentations from a range of engaging speakers and participate in the discussion.

Utredning av risiko ved utfasing av rammeavtaler med kommersielle leverandører av institusjonsplasser i barnevernet i Oslo

Court of Appeals: Excluding commercial providers from public procurement of nursing homes was unlawful

Study reveals potential for improving adherence to lipid lowering treatment

Alternative clinical endpoints: The path to better treatment?

Bergen

Oslo

Berlin